Litchfield, AZNCT07239336Now EnrollingIRB Ready

Celiac Disease Clinical Trial in Litchfield, AZ

Access cutting-edge celiac disease treatment through this clinical trial at a research site in Litchfield. Study-provided care at no cost to qualified participants.

Sponsored by Chugai Pharmaceutical

Quick Self-Assessment

See if you qualify for this Litchfield location

Preparing your pre-screening questions…

Expert Care in Litchfield

Access celiac disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related celiac disease treatment provided free

Apply for This Litchfield Location

Check if you qualify for this celiac disease clinical trial in Litchfield, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Litchfield

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Litchfield site if eligible
  4. 4Begin participation

About This Celiac Disease Study in Litchfield

The main aim is to see how DONQ52 works to improve small intestinal damage and reduce celiac-related symptoms due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.

Sponsor: Chugai Pharmaceutical

Who Can Participate

Inclusion Criteria

Body mass index (BMI) of 18 to 40 (kg/m2) at screening.
Willingness to ingest a gluten-free product and Simulated Inadvertent Gluten Exposure (SIGE) products as per the study protocol.
History of medically diagnosed, and adequately documented (i.e., included in the participant's medical records), CeD
Attempting a GFD for at least 12 months prior to the screening visit. \- The participants should be instructed not to alter dietary habits including a GFD during the study period.
Valid results from central testing of blood documenting a positive result for the HLA DQ2.5 genotype (HLA-DQA1\*05 and HLA-DQB1\*02) (homozygous or heterozygous).
Experienced at least 2 gluten-related symptom events (i.e., 2 different gluten-related symptoms which are diarrhea, abdominal pain, bloating, nausea, tiredness or 1 gluten-related symptom occurred twice) within a month before the screening.
Willingness to undergo 2 on-study upper gastrointestinal endoscopies with duodenal biopsies.
Presence of ongoing duodenal mucosal damage defined as Vh:Cd of 2.5 or less

Exclusion Criteria

Participants with documented history (i.e., included in the participant's medical records) of medically diagnosed Refractory Celiac Disease (RCD) or suspected RCD by the investigator.
History of IgE-mediated reactions to wheat, barley, rye, or other ingredients in gluten-free and SIGE products used in this study (i.e., methylcellulose, and gelatin).
History of cancer, including hematological malignancy and solid tumors, within 5 years prior to the screening visit, or history of T cell lymphoma or B cell lymphoma ever.
History of hypersensitivity reactions including anaphylaxis to a biological medical product or any of the excipients.
Participants who carry the HLA-DQ8 (HLA-DQA1\*03 and DQB1\*0302) genotype (homozygous or heterozygous).
Any other chronic, active gastrointestinal disease (e.g., inflammatory bowel disease, microscopic colitis, eosinophilic esophagitis, peptic ulcer, gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome) that might in the investigator's opinion, interfere with the assessment of GI symptoms or small intestinal histology.
Helicobacter pylori tests that indicate current infection.
Positive either human immunodeficiency virus (HIV) antigen or antibody test at screening.
Positive hepatitis B surface antigen (HBsAg) test or total hepatitis B core (HBc) antibody test at screening.
Positive hepatitis C virus (HCV) antibody test at screening, except in participants who have negative results for HCV ribonucleic acid (RNA) test at screening.
Positive for QuantiFERON-TB Gold test at screening that indicates active tuberculosis (TB) at screening.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Litchfield?

Yes, this clinical trial (NCT07239336) has an active research site in Litchfield, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Celiac Disease Treatment Options in Litchfield, AZ

If you're searching for celiac disease treatment options in Litchfield, AZ, this clinical trial (NCT07239336) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Litchfield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced celiac disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all celiac disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Litchfield, AZ

See all ankylosing spondylitis clinical trials recruiting in Litchfield — not just this study.

Browse Ankylosing Spondylitis Trials in Litchfield →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsCeliac Disease TrialsAll Conditions →

Ready to Join in Litchfield?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Litchfield, AZ